Cite
HARVARD Citation
Colombel, J. et al. (n.d.). DOP38 Upadacitinib Therapy Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy. Journal of Crohn's and colitis. pp. i102-i103. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Colombel, J. et al. (n.d.). DOP38 Upadacitinib Therapy Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy. Journal of Crohn's and colitis. pp. i102-i103. [Online].